Structure | Compound Name | Standard Type | Standard Values (in nM) |
|---|---|---|---|
| Cilengitide | IC50 | 0.54 [1] | |
| Cilengitide | Ki | 1.0 [1] | |
| Cyclo(Arg-Gly-Asp-D-Phe-Val) | IC50 | 10.8 [1] | |
| 2-[(2S)-7-[1H-Benzimidazol-2-ylmethyl(methyl)carbamoyl]-4-methyl-3-oxo-2,5-dihydro-1H-1,4-benzodiazepin-2-yl]acetic acid | IC50 | 145.0 [1] | |
| 2-[(2S)-7-[1H-Benzimidazol-2-ylmethyl(methyl)carbamoyl]-4-methyl-3-oxo-2,5-dihydro-1H-1,4-benzodiazepin-2-yl]acetic acid | Ki | 2.0 [1] | |
MLA | "Quest Database™ Integrin alpha-V/beta-3 Inhibitors (IC50, Ki)." AAT Bioquest, Inc., 5 Dec. 2025, https://www.aatbio.com/data-sets/integrin-alpha-v-beta-3-inhibitors-ic50-ki. | |
APA | AAT Bioquest, Inc. (2025, December 5). Quest Database™ Integrin alpha-V/beta-3 Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/integrin-alpha-v-beta-3-inhibitors-ic50-ki. | |
| BibTeX | EndNote | RefMan |